...
首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Biotransformation of L-cysteine S-conjugates and N-acetyl-L-cysteine S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in human kidney in vitro: interindividual variability in N-
【24h】

Biotransformation of L-cysteine S-conjugates and N-acetyl-L-cysteine S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in human kidney in vitro: interindividual variability in N-

机译:七氟醚降解产物氟甲基-2,2-二氟-1-(三氟甲基)乙烯基醚(化合物A)的L-半胱氨酸S-结合物和N-乙酰-L-半胱氨酸S-结合物在人肾脏中的体外生物转化:个体间N-的变异性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (FDVE; 1) is a fluoroalkene formed by the base-catalyzed degradation of the anesthetic sevoflurane. FDVE is nephrotoxic in rats. In both rats and humans, FDVE undergoes glutathione-dependent conjugation, cleavage to cysteine S-conjugates, and renal beta-lyase-catalyzed metabolism to reactive intermediates, which may cause nephrotoxicity. Interindividual variability in renal metabolism of FDVE is unknown. Therefore, this investigation quantified beta-lyase-catalyzed bioactivation and N-acetyltransferase-catalyzed inactivation of FDVE cysteine S-conjugates and reactivation of mercapturates by N-deacetylase in cytosol and microsomes from 20 human kidneys. In cytosol, N-acetylation ranged from 0.008 to 0.045 (0.024 +/- 0.01) nmol of mercapturate/mg/min and 0.001 to 0.07 (0.024 +/- 0.02) nmol of mercapturate/mg/min for alkane and alkene cysteine S-conjugates, respectively. Similar results for microsomal N-acetylation were obtained; N-acetylation ranged from 0.005 to 0.055 (0.025 +/- 0.02) nmol of mercapturate/mg/min and 0.001 to 0.06 (0.030 +/- 0.02) nmol of mercapturate/mg/min for alkane and alkene cysteine S-conjugates, respectively. Beta-lyase-catalyzed metabolism to pyruvate varied from 0.004 to 0.14 (0.051 +/- 0.04) nmol/mg/min and from 0.10 to 0.40 (0.26 +/- 0.08) nmol/mg/min for alkane and alkene cysteine-S-conjugates, respectively. N-deacetylation of mercapturates ranged from 0.8 to 2.5 (1.25 +/- 0.57) nmol of cysteine S-conjugate formed/mg/min and 0.05 to 0.37 (0.17 +/- 0.10) nmol of cysteine S-conjugate formed/mg/min for alkane and alkene FDVE mercapturates. Cytosolic cysteine S-conjugates metabolism by renal beta-lyase predominated over N-acetylation (ratio of activities was 0.2-6 and 3-146 for the alkane and alkene cysteine S-conjugates). N-deacetylation predominated over N-acetylation (ratio of activities was 20-205 and 2-54 for alkane and alkene S-conjugates). There was considerable (up to 50-fold) interindividual variability in rates of FDVE toxication (beta-lyase metabolism and N-deacetylation) and detoxication. This interindividual variability may effect individual susceptibility to the nephrotoxicity of FDVE and other haloalkenes.
机译:氟甲基-2,2-二氟-1-(三氟甲基)乙烯基醚(FDVE; 1)是由碱催化麻醉性七氟醚降解而形成的氟代烯烃。 FDVE在大鼠中具有肾毒性。在大鼠和人类中,FDVE都经历谷胱甘肽依赖性结合,裂解为半胱氨酸S-结合物以及肾β-裂合酶催化的代谢为反应性中间体,这可能引起肾毒性。 FDVE肾脏代谢的个体间差异尚不清楚。因此,这项研究量化了来自20个人类肾脏的FDVE半胱氨酸S-缀合物的β-裂合酶催化的生物活化和N-乙酰基转移酶催化的失活以及N-脱乙酰基酶对巯基化物的活化。在细胞质中,N-乙酰化的巯基化物/毫克/分钟的摩尔浓度为0.008至0.045(0.024 +/- 0.01)nmol,对于烷烃和半胱氨酸S-而言,N-乙酰化的巯基盐的摩尔浓度为0.001至0.07(0.024 +/- 0.02)nmol。共轭。微粒体的N-乙酰化得到了相似的结果。对于烷烃和烯烃半胱氨酸S-共轭物,N-乙酰化分别在0.005-0.055(0.025 +/- 0.02)nmol巯基/毫克/分钟和0.001-0.06(0.030 +/- 0.02)nmol巯基/毫克/分钟的范围内。 β-裂解酶催化的丙酮酸代谢为0.004至0.14(0.051 +/- 0.04)nmol / mg / min,烷烃和烯烃半胱氨酸-S-为0.10至0.40(0.26 +/- 0.08)nmol / mg / min共轭。硫醇盐的N-脱乙酰化范围为形成半胱氨酸S-缀合物的0.8至2.5(1.25 +/- 0.57)nmol / mg / min和形成半胱氨酸S-缀合物的0.05至0.37(0.17 +/- 0.10)nmol / mg / min用于烷烃和烯烃的FDVE巯基。肾β-裂合酶的胞质半胱氨酸S-缀合物代谢高于N-乙酰化(烷烃和烯烃半胱氨酸S-缀合物的活性比为0.2-6和3-146)。 N-脱乙酰基高于N-乙酰化(烷烃和烯烃S-共轭物的活性比为20-205和2-54)。 FDVE中毒(β-裂合酶代谢和N-脱乙酰基化)和脱毒的速率之间存在很大的个体差异(最多50倍)。这种个体差异可能会影响个体对FDVE和其他卤代烯烃的肾毒性的敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号